Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-lactamase Inhibitor, Dosed in Combination with Imipenem/Cilastatin in Healthy Subjects.
about
Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-lactamase Inhibitor, Dosed in Combination with Imipenem/Cilastatin in Healthy Subjects.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Intrapulmonary Pharmacokinetic ...... ilastatin in Healthy Subjects.
@en
Intrapulmonary Pharmacokinetic ...... ilastatin in Healthy Subjects.
@nl
type
label
Intrapulmonary Pharmacokinetic ...... ilastatin in Healthy Subjects.
@en
Intrapulmonary Pharmacokinetic ...... ilastatin in Healthy Subjects.
@nl
prefLabel
Intrapulmonary Pharmacokinetic ...... ilastatin in Healthy Subjects.
@en
Intrapulmonary Pharmacokinetic ...... ilastatin in Healthy Subjects.
@nl
P2093
P2860
P356
P1476
Intrapulmonary Pharmacokinetic ...... ilastatin in Healthy Subjects.
@en
P2093
Cynthia M Chavez-Eng
Elizabeth G Rhee
Eric Mangin
Joan R Butterton
Mark H Gotfried
Matthew L Rizk
Patricia A Jumes
Zufei Zhang
P2860
P356
10.1128/AAC.01411-17
P407
P577
2018-01-08T00:00:00Z